Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women
- PMID: 23798918
- PMCID: PMC3685774
Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women
Abstract
Background: This study aimed to investigate whether magnesium supplementation might affect serum magnesium, high sensitive C-reactive protein (hs-CRP), plasma fibrinogen, and interleukin 6 (IL-6) levels in healthy middle-aged overweight women. The relationships, if any, between serum magnesium and the inflammatory markers were also examined cross-sectionally in the entire participants at the beginning of the study.
Materials and methods: This double-blinded, placebo-controlled, randomized trial included 74 middle-aged overweight women. Participants were randomly assigned to receive either 250 mg magnesium as magnesium oxide or placebo daily for 8 weeks. Serum magnesium, hs-CRP, fibrinogen and IL-6 concentrations were measured before and after the intervention.
Results: Serum magnesium was found to be inversely correlated with hs-CRP (rs =-0.22, P=0.05) in the entire participants at baseline. Serum hs-CRP declined significantly in both groups as compared with baseline values (median change=0.8 mg/L; PMagnesium= 0.03, PPlacebo < 0.001). Plasma fibrinogen decreased significantly, by 9%, in the magnesium group at the end of week 8 compared to baseline (P=0.001). Mean concentration of IL-6 was significantly increased in the magnesium group comparing the baseline value(P=0.001). However hs-CRP, fibrinogen and IL-6 levels at week 8 or any changes during the study were not statistically different between the two groups. Serum magnesium showed no significant changes in any groups.
Conclusions: Serum magnesium had a significant inverse correlation with hs-CRP. In the present study, magnesium as magnesium oxide, 250 mg/day, for 8 weeks did not significantly attenuate inflammatory markers in the magnesium group as compared to the placebo.
Keywords: IL-6; Magnesium; hs-CRP; middle-aged women; overweight; systemic inflammation.
Conflict of interest statement
References
-
- Gallagher M. The nutrients and their metabolism. In: Mahan LK, Escott-Stump S, editors. Krause's food & nutrition therapy. 12th ed. Philadelphia: Saunders; 2008. pp. 110–3.
-
- Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr. 2003;133:2879–82. - PubMed
-
- King DE, Mainous AG, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr. 2005;24:166–71. - PubMed
-
- Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med. 2007;167:956–65. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous